SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a ratio of ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Bionano Genomics BNGO is set to give its latest quarterly earnings report on Thursday, 2025-08-14. Here's what investors need to know before the announcement. Analysts estimate that Bionano Genomics ...

Bionano Genomics, Inc. (BNGO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

For folks with a tolerance for risk, life sciences company Bionano Genomics (NASDAQ:BNGO) is definitely worth a look. It takes guts to invest in out-of-favor assets like BNGO stock, but the long-term ...

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) (“Bionano” or the “Company”) today announced the pricing of a public offering of an aggregate of 5,000,000 shares of the ...

Equities researchers at HC Wainwright initiated coverage on shares of Bionano Genomics (NASDAQ:BNGO – Get Free Report) in a research report issued on Wednesday, Marketbeat reports. The firm set a “buy ...

Most biopharma players need access to gene sequencing services. Illumina is facing a handful of headwinds, but it's still the market leader. Bionano Genomics is unproven but expanding quickly. So ...

Bionano Genomics (NASDAQ:BNGO) just reported results for the second quarter of 2024. Bionano Genomics reported earnings per share of -24 cents. This was above the analyst estimate for EPS of -42 cents ...

Bionano Genomics (NASDAQ:BNGO) just reported results for the fourth quarter of 2023. Bionano Genomics reported earnings per share of -96 cents. This was below the analyst estimate for EPS of -87 cents ...